A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer (Q37107395)

From Wikidata
Jump to navigation Jump to search
scientific article published in November 2011
edit
Language Label Description Also known as
English
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer
scientific article published in November 2011

    Statements

    A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer (English)
    G Somlo
    C L Martel
    S K Lau
    P Frankel
    A Hurria
    C Chung
    R Morgan
    L Leong
    M Koczywas
    M McNamara
    C A Russell
    S E Kane
    1 November 2011
    131
    899-906

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit